|
Vol. 25 • No. N1 • February 2023
In this issue:
- The assessment of blood homocysteine and S100B levels in patients with opioid use disorders
Yıldırım Ozbek S., Inanlı İ., Eren I., Cicek E., Ozbek S., Kurku H., Demirel B., Cicek İ.E., and Uygur H.
- Previously Used Substances and Predictors of Illicit Drug Use among Incarcerated Male Prisoners in Galle, Sri Lanka
Darshana N., Ruben R., and Wijesinghe C.
- Neonatal Abstinence Syndrome in Vojvodina, Serbia: Infant and Maternal Characteristics
Mijatović Jovin V., Vejnović A., Knezović G., Pavlović V., Vejnović A.-M., and Dickov I.
- The role of biopsychological factors in relapse of patients undergoing Methadone Maintenance Treatment in Iran
Motazedian S., Kheradmand A., Badiei R., Seif P., and Danesh A.
- Artistic clues to the diagnosis of bipolar dual disorder in opioid addicts. The case of Nachtmystium
Pacini M., and Maremmani I.
|
|
|
Vol. 25 • No. N2 • April 2023
In this issue:
- The effect of Raha syrup on the development of morphine tolerance and dependence on rats
Haerifar F., Zahedi-Khorasani M., Ghanbari A., and Miladi-Gorji H.
- The impact of COVID-19 pandemic on pregnant women with Substance Use Disorder (SUD): a narrative review
Caglioni M., Ragona A., Maremmani A.G.I., Silvia C., and Cerniglia L.
- Maternal Methadone Split Dosing in Pregnancy
Flores C., and Riaz U.
- CYP genetic polymorphism, pharmacokinetics of methadone, and the biggest risks
Jovanovic M., Bozovic N., Rancic N., Pjevac A., Rascanin S., and Stojkovic M.
- Insight in dual disorder heroin addicts. Are they able to request adequate treatment?
Pacini M., Maremmani A.G.I., Della Rocca F., Miccoli M., and Maremmani I.
|
|
|
Vol. 25 • No. N3 • June 2023
In this issue:
- Positive Psychology as a Protective Factor for Illicit Opioids in Individuals Receiving Methadone Treatment.
Krembuszewski B., Anderson-White E., Henderson C., White S., and Langley H.
- Effect of Raha Syrup on the Severity of Dependence, Depression, Anxiety, Stress, Craving and Serum Serotonin Levels in Patients with Opioid Use Disorder Receiving the Opium Tincture Maintenance Treatment
Shokravian M., Miladi-Gorji H., Shajiee H., Ghorbani R., and Mazinani M.
- Telemedicine in Addictions: Feasibility Randomised Controlled Trial
Mayet S., Gledhill A., McCaw I., Hashmani Z., Drozdova Z., Arshad S., Shahbaz S., Huang C., and Phillips T.
- Cocaine Use in Opioid and Alcohol Substance Use Disorders
Pacini M., Della Rocca F., Maremmani A.G.I., and Maremmani I.
|
|
|
Vol. 25 • No. N4 • August 2023
In this issue:
- Characteristics of opioid-dependent patients choosing antagonist treatment with extended-release naltrexone compared with patients in opioid maintenance treatment in Norway
Weimand B., Karlsson A.T., Solli K.K., Vederhus J.-K., Mordal J., Wergeland Digranes L., and Tanum L.
- Evaluating α-synuclein, dopamine and serotonin concentrations in the blood of patients with heroin use disorder: Baseline and post-treatment comparisons
Yazla E., Cetin I., and Kayadibi H.
- Exposure and addiction rates to substances and behaviours among Israeli university students
Snits A., Rozner L., Shoshan S., and Peles E.
- Differences in the time needed for solid versus liquid delivery of methadone for patients with Opioid Use Disorder in Italy: The SO.LI.D.O 2 study
Bruno G.M., Caruggi M., Ciccarone A., Valentino M.C., Ariano V., De Fazio S., Leonardi C., Ventre G., Riglietta M., Somaini L., Corbetta Andrea for the SO.LI.D.O. 2 Group, and Colombo G.L.
- Trends of hospital admissions for alcohol, cannabinoids, benzodiazepines and heroin-related intoxications among children, adolescents and young adults in Slovenia in the years 1999–2019 and the possible impact of economic crisis
Lovrecic B., Lovrecic M., Simon M.R., Korosec A., Stibernik M., and Maremmani A.G.I.
|
